Clinical Trial

Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation

Study acronym: PULSAR PAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the long-term safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal atrial fibrillation.
Trial Details
NCT Number NCT07714876
Lead Sponsor Kardium Inc.
Conditions Paroxysmal Atrial Fibrillation
Enrollment 250 participants
Start Date 2026-12
Primary Completion 2029-12 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-20